Search

Home > High on Life > Retatrutide - Top-Line Results from TRIUMPH 4
Podcast: High on Life
Episode:

Retatrutide - Top-Line Results from TRIUMPH 4
Category: Health
Duration: 00:06:33
Publish Date: 2025-12-11 21:00:00
Description:

In this quick update, I break down the newest Phase 3 data for retatrutide, Lilly’s investigational triple-agonist medication showing unprecedented results in obesity and knee osteoarthritis.

Highlights:

  • Up to 28.7% weight loss (~71 lbs) over 68 weeks
  • 75% reduction in knee pain and major improvements in physical function
  • Cardiometabolic benefits: lower triglycerides, non-HDL cholesterol, hsCRP, and blood pressure

We also cover

  • Common side effects and safety signals
  • Perceived excessive weight loss — and what this means for clinical practice in a new era of powerful medications
  • A reality check on Canadian availability (likely 3+ years away)
  • A strong warning about illegal online sales and the risks of buying unregulated products

A concise medical breakdown to help you stay informed and safe as the obesity-medicine landscape evolves.
Total Play: 0